These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 26567751

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P, Kiss I, Klusova S, Hlavsa J, Prochazka V, Kala Z, Mazanec J, Hausnerova J, Kren L, Hermanova M, Lenz J, Karasek P, Vyzula R, Slaby O.
    Diagn Pathol; 2015 Apr 24; 10():38. PubMed ID: 25908274
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.
    JAMA; 2015 Apr 24; 311(4):392-404. PubMed ID: 24449318
    [Abstract] [Full Text] [Related]

  • 25. A microRNA meta-signature for pancreatic ductal adenocarcinoma.
    Frampton AE, Giovannetti E, Jamieson NB, Krell J, Gall TM, Stebbing J, Jiao LR, Castellano L.
    Expert Rev Mol Diagn; 2014 Apr 24; 14(3):267-71. PubMed ID: 24575833
    [Abstract] [Full Text] [Related]

  • 26. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, González Maldonado S, Pilarsky C, Heidecke CD, Schatz P, Distler M, Scheiber JA, Mahajan UM, Weiss FU, Grützmann R, Lerch MM.
    Gut; 2018 Jan 24; 67(1):128-137. PubMed ID: 28108468
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
    Carlsen AL, Joergensen MT, Knudsen S, de Muckadell OB, Heegaard NH.
    Pancreas; 2013 Oct 24; 42(7):1107-13. PubMed ID: 24048453
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA, Mees ST.
    Ann Surg Oncol; 2009 Nov 24; 16(11):3183-9. PubMed ID: 19636633
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M, Occhipinti G, Principato G, Piva F.
    Cell Oncol (Dordr); 2017 Apr 24; 40(2):181-192. PubMed ID: 28205147
    [Abstract] [Full Text] [Related]

  • 33. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.
    Makler A, Asghar W.
    Int J Mol Sci; 2023 Mar 07; 24(6):. PubMed ID: 36982154
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
    Yu Q, Xu C, Yuan W, Wang C, Zhao P, Chen L, Ma J.
    Biomed Res Int; 2017 Mar 07; 2017():6495867. PubMed ID: 28466015
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
    Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2009 Sep 07; 2(9):807-13. PubMed ID: 19723895
    [Abstract] [Full Text] [Related]

  • 38. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA, Kholy ZA, Anwar MM, Ahmad MA, Ahmad SM.
    J Cancer Res Clin Oncol; 2017 Jan 07; 143(1):83-93. PubMed ID: 27631726
    [Abstract] [Full Text] [Related]

  • 39. Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis.
    Kakkat S, Rajan R, Sindhu RS, Natesh B, Raviram S.
    Indian J Gastroenterol; 2017 Jul 07; 36(4):263-267. PubMed ID: 28916969
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.